DISOPYRAMIDE IS FIRST POST-1962 ANDA APPROVED; BIOCRAFT RECEIVES FDA APPROVAL ON FEB. 22 FOR GENERIC NORPACE; FIRM SEEKS TO RAISE $8 - $10 MIL. VIA FIRST OFFERING

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".